Proglucagon-derived peptides in intestinal epithelial proliferation: Glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats

Mohammad A. Ghatei, Robert A. Goodlad, Shahrad Taheri, Nikki Mandir, Audrey E. Brynes, Mark Jordinson, Stephen R. Bloom

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Proglucagon-derived peptides have been implicated in the control of intestinal mucosal cell division. To investigate the actions of these peptides on intestinal cell proliferation, different doses of enteroglucagon, oxyntomodulin, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) were tested in male Wistar rats maintained on total parenteral nutrition. Crypt cell proliferation was assessed by the analysis of arrested metaphases in microdissected crypts. Enteroglucagon and oxyntomodulin had no effect on intestinal weight or cell proliferation. GLP-1 had a slight effect on stomach and small intestinal weights and on epithelial cell proliferation in the small and large intestines. GLP-2 infusion dose-dependently increased the weights of the stomach, small intestine, colon, and cecum and increased crypt cell proliferation in the small and large intestines of parenterally fed rats. In orally fed animals, GLP-2 increased intestinal weight but had little effect on proliferation. Therefore, of the proglucagon-derived peptides, GLP-2 appears to be a major mediator of intestinal epithelial proliferation.

Original languageEnglish
Article number340940
Pages (from-to)1255-1263
Number of pages9
JournalDigestive Diseases and Sciences
Volume46
Issue number6
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Glucagon-Like Peptide 2
Proglucagon
Cell Proliferation
Oxyntomodulin
Peptides
Glucagon-Like Peptides
Small Intestine
Weights and Measures
Glucagon-Like Peptide 1
Large Intestine
Stomach
Cecum
Total Parenteral Nutrition
Metaphase
Cell Division
Wistar Rats
Colon
Epithelial Cells

Keywords

  • Glucagon-like peptide-2
  • Intestinal epithelial proliferation
  • Proglucagon-derived peptides
  • Rat
  • Total parenteral nutrition

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Proglucagon-derived peptides in intestinal epithelial proliferation : Glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. / Ghatei, Mohammad A.; Goodlad, Robert A.; Taheri, Shahrad; Mandir, Nikki; Brynes, Audrey E.; Jordinson, Mark; Bloom, Stephen R.

In: Digestive Diseases and Sciences, Vol. 46, No. 6, 340940, 2001, p. 1255-1263.

Research output: Contribution to journalArticle

Ghatei, Mohammad A. ; Goodlad, Robert A. ; Taheri, Shahrad ; Mandir, Nikki ; Brynes, Audrey E. ; Jordinson, Mark ; Bloom, Stephen R. / Proglucagon-derived peptides in intestinal epithelial proliferation : Glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. In: Digestive Diseases and Sciences. 2001 ; Vol. 46, No. 6. pp. 1255-1263.
@article{539b202750a244f18124132160f73103,
title = "Proglucagon-derived peptides in intestinal epithelial proliferation: Glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats",
abstract = "Proglucagon-derived peptides have been implicated in the control of intestinal mucosal cell division. To investigate the actions of these peptides on intestinal cell proliferation, different doses of enteroglucagon, oxyntomodulin, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) were tested in male Wistar rats maintained on total parenteral nutrition. Crypt cell proliferation was assessed by the analysis of arrested metaphases in microdissected crypts. Enteroglucagon and oxyntomodulin had no effect on intestinal weight or cell proliferation. GLP-1 had a slight effect on stomach and small intestinal weights and on epithelial cell proliferation in the small and large intestines. GLP-2 infusion dose-dependently increased the weights of the stomach, small intestine, colon, and cecum and increased crypt cell proliferation in the small and large intestines of parenterally fed rats. In orally fed animals, GLP-2 increased intestinal weight but had little effect on proliferation. Therefore, of the proglucagon-derived peptides, GLP-2 appears to be a major mediator of intestinal epithelial proliferation.",
keywords = "Glucagon-like peptide-2, Intestinal epithelial proliferation, Proglucagon-derived peptides, Rat, Total parenteral nutrition",
author = "Ghatei, {Mohammad A.} and Goodlad, {Robert A.} and Shahrad Taheri and Nikki Mandir and Brynes, {Audrey E.} and Mark Jordinson and Bloom, {Stephen R.}",
year = "2001",
doi = "10.1023/A:1010615429639",
language = "English",
volume = "46",
pages = "1255--1263",
journal = "American Journal of Digestive Diseases",
issn = "0002-9211",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Proglucagon-derived peptides in intestinal epithelial proliferation

T2 - Glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats

AU - Ghatei, Mohammad A.

AU - Goodlad, Robert A.

AU - Taheri, Shahrad

AU - Mandir, Nikki

AU - Brynes, Audrey E.

AU - Jordinson, Mark

AU - Bloom, Stephen R.

PY - 2001

Y1 - 2001

N2 - Proglucagon-derived peptides have been implicated in the control of intestinal mucosal cell division. To investigate the actions of these peptides on intestinal cell proliferation, different doses of enteroglucagon, oxyntomodulin, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) were tested in male Wistar rats maintained on total parenteral nutrition. Crypt cell proliferation was assessed by the analysis of arrested metaphases in microdissected crypts. Enteroglucagon and oxyntomodulin had no effect on intestinal weight or cell proliferation. GLP-1 had a slight effect on stomach and small intestinal weights and on epithelial cell proliferation in the small and large intestines. GLP-2 infusion dose-dependently increased the weights of the stomach, small intestine, colon, and cecum and increased crypt cell proliferation in the small and large intestines of parenterally fed rats. In orally fed animals, GLP-2 increased intestinal weight but had little effect on proliferation. Therefore, of the proglucagon-derived peptides, GLP-2 appears to be a major mediator of intestinal epithelial proliferation.

AB - Proglucagon-derived peptides have been implicated in the control of intestinal mucosal cell division. To investigate the actions of these peptides on intestinal cell proliferation, different doses of enteroglucagon, oxyntomodulin, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) were tested in male Wistar rats maintained on total parenteral nutrition. Crypt cell proliferation was assessed by the analysis of arrested metaphases in microdissected crypts. Enteroglucagon and oxyntomodulin had no effect on intestinal weight or cell proliferation. GLP-1 had a slight effect on stomach and small intestinal weights and on epithelial cell proliferation in the small and large intestines. GLP-2 infusion dose-dependently increased the weights of the stomach, small intestine, colon, and cecum and increased crypt cell proliferation in the small and large intestines of parenterally fed rats. In orally fed animals, GLP-2 increased intestinal weight but had little effect on proliferation. Therefore, of the proglucagon-derived peptides, GLP-2 appears to be a major mediator of intestinal epithelial proliferation.

KW - Glucagon-like peptide-2

KW - Intestinal epithelial proliferation

KW - Proglucagon-derived peptides

KW - Rat

KW - Total parenteral nutrition

UR - http://www.scopus.com/inward/record.url?scp=0034995864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034995864&partnerID=8YFLogxK

U2 - 10.1023/A:1010615429639

DO - 10.1023/A:1010615429639

M3 - Article

C2 - 11414302

AN - SCOPUS:0034995864

VL - 46

SP - 1255

EP - 1263

JO - American Journal of Digestive Diseases

JF - American Journal of Digestive Diseases

SN - 0002-9211

IS - 6

M1 - 340940

ER -